“Cholecystectomy is the seventh most common operation in the United States, with 605,000 minimally invasive ambulatory, 280,000 minimally invasive inpatient, and 49,000 inpatient open procedures annually. It is ranked 10th of all principal operative procedures in aggregate annual cost ($4.3 billion). As such, managing the cost of cholecystectomy has the potential to impact health care finances. RC consistently has been shown to be more costly than LC. 5 Despite this, the percentage of RC in the United States has increased rapidly as the robotic platform becomes more accessible in hospitals, surgeon interest grows, and marketing has increased. Because third-party reimbursement is not dependent on the platform, additional costs burden hospitals and should be theoretically offset by improved patient outcomes or other indirect benefits.”